A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013

Clinical Infectious Diseases

Volumn 60, Issue 3, 2015, Pages 333-337

  Dabrera, Gavin ^a,b   Amirthalingam, Gayatri ^a   Andrews, Nick ^a   Campbell, Helen ^a   Ribeiro, Sonia ^a   Kara, Edna ^a   Fry, Norman K ^a   Ramsay, Mary ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

case control study; England; pertussis; vaccination; Wales

Indexed keywords

PERTUSSIS VACCINE;

ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENERAL PRACTITIONER; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERTUSSIS; PREGNANCY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNITED KINGDOM; VACCINATION; ENGLAND; WALES; WHOOPING COUGH;

CASE-CONTROL STUDIES; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS VACCINE; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; VACCINATION; WALES; WHOOPING COUGH;

EID: 84922477208     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu821     Document Type: Article

References (27)

1. Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis in vaccination in protecting newborn infants in England and Wales, 2012-2013. Clin Infect Dis 2015; 60: 333-7
2. Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014; doi: 10.1016/S0140-6736(14) 60686-3
3. Housey M, Zhang F, Miller C, et al. Vaccination with tetanus, diphtheria, and acellular pertussis vaccine of pregnant women enrolled in Medicaid-Michigan, 2011-2013. MMWR Morb Mortal Wkly Rep 2014; 63: 839-42
4. Harriman K, Winter K. Pertussis vaccine uptake during pregnancy: we need to do better in the U.S. Prev Med 2014; 67: 320-1
5. Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women-United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014; 63: 816-21
6. Cherry JD. Epidemic pertussis in 2012-The resurgence of a vaccine-preventable disease. N Engl J Med 2012; 367: 785-7
7. Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012; 129: 968-70
8. Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013; 9: e1003418
9. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R.Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012; 367: 1012-9
10. Koepke R, Eickhoff JC, Ayele RA, et al. Estimating the effectiveness of tetanus-diphtheria-Acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis 2014; 210: 942-53
11. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012; 308: 454-6
12. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014; 111: 787-92
13. Cherry JD, Heininger U, Richards DM, et al. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol 2010; 17: 741-7
14. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16: 1901-6
15. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996; 334: 341-8
16. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334: 349-55
17. Olin P, Rasmussen F, Gustafsson L, Hallander HO, Heijbel H. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997; 350: 1569-77
18. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16: 1907-16
19. Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014; 311: 1760-9
20. Warfel JM, Papin JF, Wolf RF, Zimmerman LI, Merkel TJ. Maternal and neonatal vaccination protects newborn baboons from pertussis infection. J Infect Dis 2014; 210: 604-10
21. Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014; 21: 119-25
22. Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults-A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013; 31: 5178-91
23. Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis: implications for immunization. Expert Rev Vaccines 2014; 13: 1115-23
24. Murray EL. Characteristics of severe Bordetella pertussis infection among infants 90 days of age admitted to pediatric intensive care units-southern California, September 2009-June 2011 Pediatr Infect Dis Soc 2013 2 1-6
25. Paddock CD, Sanden GN, Cherry JD, et alPathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008; 47: 328-38
26. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326-82
27. Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014; 349: g4219